The effect of decitabine dose modification and myelosuppression on response and survival in patients with myelodysplastic syndromes.
The effect of decitabine dose modification and myelosuppression on response and survival in patients with myelodysplastic syndromes. Leuk Lymphoma. 2015 Feb; 56(2):390-4.